A novel fusion variant LSM14A :: NR4A3 in extraskeletal myxoid chondrosarcoma
Résumé
Abstract Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue neoplasm of uncertain lineage characterized by the pathognomonic rearrangement of the NR4A3 gene, which in most cases is fused with EWSR1. Other NR4A3 fusion partners have been described, namely TAF15 , FUS , TCF12, and TGF . Some studies suggest that EMCs with non‐ EWSR1 variant fusion are associated with high‐grade morphology and worst clinical behavior compared to EWSR1::NR4A3 tumors, supporting the potential significance of particular fusion variant in EMC. We report a case of a 34‐year‐old male who presented with calf EMC and subsequently developed a slowly progressive metastatic disease 3 years after diagnosis. Whole‐transcriptome analysis with total RNA sequencing enabled identification of a novel fusion transcript LSM14A::NR4A3 , expanding the molecular spectrum of EMC.
Domaines
Cancer| Origine | Publication financée par une institution |
|---|---|
| licence |
